Evaluation of the central properties of several Hypericum species from the Canary Islands

The infusions of the aerial parts in blossom of Hypericum canariense, H. glandulosum, H. reflexum and H. grandifolium (Hypericaceae) were evaluated for their pharmacological activity on the central nervous system in mice using various behavioural models including locomotor and muscle relaxant activity, effect on normal body temperature, pentobarbital‐induced sleep, oxotremorine and tetrabenazine‐induced syndrome, apomorphine‐induced hypothermia and 5‐hydroxytryptophan‐induced head twitches, as well as a forced swimming test. These infusions did not alter significantly the locomotor activity, pentobarbital induced sleeping time and body temperature, with the exception of H. canariense which produced a slight but significant hypothermia. Additionally, no muscle relaxant or anticholinergic activity were observed. These infusions antagonized the ptosis and/or motor depression induced by tetrabenazine as well as shortening the immobility time in the forced swimming test. The observations suggest that the infusions of these Hypericum species possess antidepressant activity in mice, without inducing muscle relaxation, anticholinergic and sedative properties. Copyright © 2002 John Wiley & Sons, Ltd.

[1]  A. Puech,et al.  Antagonism of hypothermia and behavioral response to apomorphine: A simple, rapid and discriminating test for screening antidepressants and neuroleptics , 2004, Psychopharmacology.

[2]  B. Gurley,et al.  Drug Interaction between St. John's Wort and Cyclosporine , 2000, The Annals of pharmacotherapy.

[3]  J. Falloon,et al.  Indinavir concentrations and St John's wort , 2000, The Lancet.

[4]  B. Gaster,et al.  St John's wort for depression: a systematic review. , 2000, Archives of internal medicine.

[5]  I. Roots,et al.  Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) , 1999, Clinical pharmacology and therapeutics.

[6]  E. Ernst,et al.  Safety of Hypericum in Patients with Depression , 1999 .

[7]  D. Wheatley Hypericum Extract , 1998 .

[8]  A. Nahrstedt,et al.  Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. , 1997, Pharmacopsychiatry.

[9]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[10]  M. Bourin Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? , 1990, Fundamental & clinical pharmacology.

[11]  R. Shank,et al.  Preclinical evaluation of McN-5707 as a potential antidepressant. , 1987, The Journal of pharmacology and experimental therapeutics.

[12]  V. Darias,et al.  Contribution to the ethnopharmacological study of the Canary Islands. , 1986, Journal of ethnopharmacology.

[13]  R. Tallarida,et al.  Manual of Pharmacologic Calculations , 1981 .

[14]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.